Featured Research

from universities, journals, and other organizations

Safeguards needed to prevent discrimination of early Alzheimer's patients in the workplace

Date:
September 20, 2011
Source:
University of Pennsylvania School of Medicine
Summary:
Despite the emergence of new tools that can diagnose Alzheimer's earlier, no effective interventions have been identified to stop the progression of the disease. A new report tackles the ethical and logistical challenges of safely and effectively communicating a diagnosis of pre-clinical Alzheimer's disease in light of the gulf between diagnosis and treatment.

The changing tide of Alzheimer's diagnosis presents new challenges to the public, physicians and lawmakers: if you could find out your Alzheimer's risk, would you want to know? How should doctors tell you your risk? And what does it mean for the many newly diagnosed Americans still in the workplace?

Related Articles


Despite the emergence of new tools that can diagnose Alzheimer's earlier, no effective interventions have been identified to stop the progression of the disease. A new report from the Perelman School of Medicine at the University of Pennsylvania tackles the ethical and logistical challenges of safely and effectively communicating a diagnosis of pre-clinical Alzheimer's disease in light of the gulf between diagnosis and treatment. The study appears in the October 11 print edition of Neurology.

Alzheimer's disease is among the most feared diseases of aging. The disease has been known for its role in memory loss and other clinical symptoms. But increasingly, patients learn they have the disease before symptoms start impacting their ability to function in daily life.

"We need to develop systems now, to navigate the challenges of a pre-clinical Alzheimer's diagnosis," said Jason Karlawish, MD, Professor of Medicine and Medical Ethics, author of the paper and leading voice on the ethics of Alzheimer's. "It's only a matter of time before we are able identify Alzheimer's before the patient is ill, like we've done with cholesterol and heart disease. Given the unique nature of this disease, which strips people of their independence as the disease progresses, safeguards are needed to protect those at high risk or with a pre-clinical diagnosis."

On the individual level, people strongly differ in their desire to know their risk and will react differently to a high Alzheimer's risk score or diagnosis in the early stages of the disease. In some cases, biomarker test results can be harmful; patients may develop anxiety or serious depression. To safely and effectively communicate a diagnosis of pre-clinical Alzheimer's disease, Dr. Karlawish recommends that researchers and clinicians track the emotional and physical impact of a pre-clinical diagnosis, then develop and disseminate best practices.

When an effective Alzheimer's therapy or intervention is found, a process will be necessary to ensure the patients who stand to benefit most are prioritized accordingly. Both prognostic and predictive evidence should be gauged against not only an individual's risk but the entire population at risk, especially if failure to intervene could cause large numbers of people to be impacted by any disease progression. A "National Alzheimer's Education Program" is proposed, to address how to translate research results into clinical practice for those with pre-clinical disease.

"The Alzheimer's disease label does not equate to disability," said Dr. Karlawish. In order to ensure that patients' daily lives (i.e. driving, financial planning, work status) aren't negatively or prematurely limited, laws and policies need to be revised to prevent stigma, discrimination and, when patients do suffer disability, exploitation.

"The discovery of pre-clinical Alzheimer's disease may be how we prevent the tsunami of Alzheimer's disease dementia, but we must not drown in the challenges created by our own discovery," warned Dr. Karlawish.

The study was sponsored by the Marian S. Ware Alzheimer Program and a Robert Wood Johnson Investigator Award in Health Policy Research.


Story Source:

The above story is based on materials provided by University of Pennsylvania School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. Karlawish. Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease. Neurology, 2011; DOI: 10.1212/WNL.0b013e318232ac1a

Cite This Page:

University of Pennsylvania School of Medicine. "Safeguards needed to prevent discrimination of early Alzheimer's patients in the workplace." ScienceDaily. ScienceDaily, 20 September 2011. <www.sciencedaily.com/releases/2011/09/110915171632.htm>.
University of Pennsylvania School of Medicine. (2011, September 20). Safeguards needed to prevent discrimination of early Alzheimer's patients in the workplace. ScienceDaily. Retrieved March 29, 2015 from www.sciencedaily.com/releases/2011/09/110915171632.htm
University of Pennsylvania School of Medicine. "Safeguards needed to prevent discrimination of early Alzheimer's patients in the workplace." ScienceDaily. www.sciencedaily.com/releases/2011/09/110915171632.htm (accessed March 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, March 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins